Inflammation and the apopto-phagocytic system

Although under normal conditions many cells die daily mainly by apoptosis in human tissues, inflammation does not occur. The redundant function of a relatively large number of molecules are available to recognize changes occurring on the surface of apoptotic cells, to opsonize the dead cells and to...

Full description

Saved in:
Bibliographic Details
Published in:Immunology Letters 2006-04, Vol.104 (1), p.94-101
Main Authors: Májai, Gyöngyike, Petrovski, Goran, Fésüs, László
Format: Article
Language:English
Subjects:
Animals
Apoptosis
Apoptosis - immunology
Autoimmunity
Humans
Immunity, Innate
Inflammation - immunology
Innate immunity
Macrophages
Mice
Non-professional phagocytes
Phagocytes - immunology
Phagocytosis
Pro-inflammatory and anti-inflammatory cytokines
Signaling
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although under normal conditions many cells die daily mainly by apoptosis in human tissues, inflammation does not occur. The redundant function of a relatively large number of molecules are available to recognize changes occurring on the surface of apoptotic cells, to opsonize the dead cells and to engulf the apoptotic cells previously opsonized or not. Several components of the innate immune system are utilized in this process, mainly soluble factors which bind to the distinct molecular pattern of apoptotic cells. These cells, unlike necrotic ones, do not induce the expression of inflammatory cytokines in phagocytic cells, they can even inhibit such a response and engage an active signaling process to elicit a direct anti-inflammatory effect. The molecular details of these signaling processes have not been clarified yet. Both professional and “amateur” cells can engulf apoptotic cells and mediate an anti-inflammatory action. Disturbance of these processes have significant roles in development of autoimmune diseases and highly malignant tumors.
ISSN:0165-2478
1879-0542
1365-2567
DOI:10.1016/j.imlet.2005.11.016